Скачать или смотреть 2022 Health Care Outlook: How the Biotech Industry is Adapting to COVID-19 | J.P. Morgan

What are some of the key themes for the biotech industry in 2022? Jess Fye, Senior Analyst for U.S. Biotechnology at J.P. Morgan Research discusses the outlook for the sector, highlighting major themes including M&A activity, the IPO pipeline, and innovation in cell and gene therapy.

SUBSCRIBE: http://jpm.com/x/i/NFPWfK0

About J.P. Morgan:
J.P. Morgan is a leader in financial services, offering solutions to clients in more than 100 countries with one of the most comprehensive global product platforms available. We have been helping our clients to do business and manage their wealth for more than 200 years. Our business has been built upon our core principle of putting our clients' interests first.

Connect with J.P. Morgan Online:
Visit the J.P. Morgan Website: https://www.jpmorgan.com/
Follow @jpmorgan on Twitter:   / jpmorgan  
Visit our J.P. Morgan Facebook page:   / jpmorgan  
Follow J.P. Morgan on LinkedIn:   / j-p-morgan  
Follow @jpmorgan on Instagram:   / jpmorgan  

#JPMorgan #HealthcareOutlook #Biotech
2022 Health Care Outlook: How the Biotech Industry is Adapting to COVID-19 | J.P. Morgan